Rocket Lab USA RKLB · NASDAQ
$52.60 +2.69% (+$1.38)
Summary
35 / 100 · Bulios Score
What speaks for it
- Revenue grew by 42% a year over the last 3 years.
- It holds more cash than debt: $2.13B against $133.7M.
- Analysts expect revenue to grow by 59% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
- It passes only 3 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 76% a year over 5 years. Over the last 3 years it grew by 42% a year. For the next fiscal year analysts expect revenue to grow by 59%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $165.5M.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 16
- Hold 4
- Sell 1
Today's price within the analysts' price targets
The average target of $107 is 103% above today's price. 76% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
- Space Systems 71%
- Launch Services 29%
By region
- UNITED STATES 62%
- CANADA 24%
- Rest Of World 7.5%
- JAPAN 7.0%
Space Systems brings in 71% of revenue.
Segments in detail